Skip to content

Breast Cancer Health Center

Select An Article

Biological Therapy for Breast Cancer

Font Size

Biological therapy for breast cancer uses the body's immune system or hormonal system to treat cancer cells. This causes less harm to healthy cells: Side effects from biological therapy aren’t as bad as from better-known treatments like chemotherapy.

One type of biological therapy uses antibodies to attack cancer cells or block them from growing. Antibodies are a part of the immune system made by special white blood cells. They can also be made in a lab and given as medicine.

Recommended Related to Breast Cancer

Breast Cancer Awareness Month: Me and the Girls

"You have breast cancer." This year, nearly 250,000 women in the U.S. will hear those words. Last year, Zunilda Guzman was one of them. "I was devastated," says Guzman, 39. "I wanted the world to end." But Guzman, mother to a 9-year-old daughter, knew she couldn't let that happen. And neither did any of the other nine breast cancer survivors interviewed by WebMD as part of a special project for Breast Cancer Awareness Month. Their stories relay important messages about prevention, screening,...

Read the Breast Cancer Awareness Month: Me and the Girls article > >

Another type of biological therapy uses drugs made of small molecules that interrupt signals that cancer cells need to grow.

HER2-Positive Breast Cancer

One example of a man-made antibody is trastuzumab (Herceptin). Herceptin is believed to stop cancer cells from growing in three ways:

  1. It sticks to special receptors on cancer cells, stopping them from growing.
  2. It signals the body's immune system to attack cancer cells.
  3. It can improve the effectiveness of chemotherapy.

But Herceptin works only if the patient has the HER2 gene in her cancer cells. About 30% of breast cancer patients have this gene; they are called "HER2-positive."

Herceptin is the standard treatment for HER2-positive breast cancer, and it's used in combination with one of the drugs known as taxanes (Abraxane, Taxol, and Taxotere).

Pertuzumab (Perjeta) is another antibody used to treat HER2-positive breast cancer. It's used in combination with Herceptin and Taxotere.

Another medication, ado-trastuzumab emtansine (Kadcyla), combines the antibody in Herceptin with a chemotherapy drug. It's used in patients with HER2-positive, metastatic breast cancer who were previously treated with a combination of Herceptin and a taxane.

One disadvantage of antibody treatment is that it is generally available only by injection. Small-molecule treatment can be taken in a pill.

Lapatinib (Tykerb) is an example of a small-molecule drug. It's used in combination with chemotherapy to treat some advanced cases of HER2-positive breast cancer. It’s often used when other cancer medications have been tried and weren't successful.

HER2-Negative Breast Cancer

Women who don’t have the HER2 gene are called "HER2-negative." These women need different cancer treatments than HER2-positive women.

Next Article:

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
 
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
 
Breast Cancer Treatments Improving
VIDEO
Resolved To Quit Smoking
SLIDESHOW
 
Woman getting mammogram
Article
Screening Tests for Women
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
serious woman
Article
 
what is your cancer risk
HEALTH CHECK
10 Ways to Revitalize Slideshow
SLIDESHOW